Dizocilpine derivatives as peripheral NMDA receptor antagonists
US11944616B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 26, 2022 |
| Grant date | Apr 2, 2024 |
| Priority date | — |
| Expiry date | Oct 14, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D451/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I): for use as peripheral NMDA receptor antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.